ProShare Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.3M Sell
4,291
-597
-12% -$181K ﹤0.01% 743
2025
Q1
$1.62M Sell
4,888
-1,208
-20% -$400K ﹤0.01% 700
2024
Q4
$1.88M Buy
6,096
+1,498
+33% +$462K ﹤0.01% 707
2024
Q3
$976K Buy
4,598
+1,300
+39% +$276K ﹤0.01% 819
2024
Q2
$924K Sell
3,298
-756
-19% -$212K ﹤0.01% 764
2024
Q1
$1.08M Buy
4,054
+343
+9% +$91.6K ﹤0.01% 769
2023
Q4
$859K Buy
3,711
+734
+25% +$170K ﹤0.01% 801
2023
Q3
$435K Buy
2,977
+22
+0.7% +$3.21K ﹤0.01% 976
2023
Q2
$683K Buy
2,955
+199
+7% +$46K ﹤0.01% 828
2023
Q1
$668K Sell
2,756
-297
-10% -$72K ﹤0.01% 812
2022
Q4
$886K Buy
+3,053
New +$886K ﹤0.01% 763
2022
Q2
Sell
-3,976
Closed -$391K 1985
2022
Q1
$391K Sell
3,976
-1,003
-20% -$98.6K ﹤0.01% 1455
2021
Q4
$422K Sell
4,979
-20
-0.4% -$1.7K ﹤0.01% 1571
2021
Q3
$399K Sell
4,999
-927
-16% -$74K ﹤0.01% 1351
2021
Q2
$577K Buy
5,926
+1,374
+30% +$134K ﹤0.01% 1430
2021
Q1
$532K Buy
4,552
+226
+5% +$26.4K ﹤0.01% 1394
2020
Q4
$481K Buy
+4,326
New +$481K ﹤0.01% 1299
2018
Q4
Sell
-1,142
Closed -$245K 1648
2018
Q3
$245K Buy
1,142
+376
+49% +$80.7K ﹤0.01% 1477
2018
Q2
$214K Buy
+766
New +$214K ﹤0.01% 1574
2016
Q2
Sell
-318
Closed -$3K 1606
2016
Q1
$3K Sell
318
-60
-16% -$566 ﹤0.01% 1592
2015
Q4
$5K Sell
378
-2,843
-88% -$37.6K ﹤0.01% 1719
2015
Q3
$196K Sell
3,221
-175
-5% -$10.6K ﹤0.01% 1323
2015
Q2
$265K Buy
3,396
+531
+19% +$41.4K ﹤0.01% 1359
2015
Q1
$195K Buy
2,865
+406
+17% +$27.6K ﹤0.01% 1725
2014
Q4
$228K Buy
2,459
+186
+8% +$17.2K ﹤0.01% 1682
2014
Q3
$239K Sell
2,273
-152
-6% -$16K ﹤0.01% 1863
2014
Q2
$347K Sell
2,425
-885
-27% -$127K ﹤0.01% 1809
2014
Q1
$499K Buy
3,310
+2,162
+188% +$326K 0.01% 1872
2013
Q4
$211K Sell
1,148
-277
-19% -$50.9K ﹤0.01% 1247
2013
Q3
$315K Buy
1,425
+309
+28% +$68.3K 0.01% 1867
2013
Q2
$195K Buy
+1,116
New +$195K ﹤0.01% 2048